Genmab — Juni 2018

[Sukkeralf]

(clinicaltrials.gov)

[Sukkeralf]

Det var den her der skulle på før

[E_L]

that website does not seem legit, they seem to be taking their info from this twitter conversation https://twitter.com/EgidiusLambrech/status/1006182910175703040

[E_L]

so a rumour until confirmed.

[E_L]

Genmab should clarify. asap. you don't want people to second guess and start rumours. I copied Rachel on twitter.

[Mcjean]

But E L Alf's link isnt it a updated version and what they talked about is actually number 4?

[Mcjean]

its not updated i guess

[Sukkeralf]

But on clinical trials the new studies were posted 6 and 11 june

[Sukkeralf]

Strange thing if you put them on just to remove them again

[Mcjean]

Kunne være skægt hvis det viser sig de starter op, hvad vil de store analytiske genier så gøre:-) Opjustere med 1 kr.

[Bulder]

Det studie der blev "discontinued" i pressemeddelelsen var MMY2036. Og der er det der tales om her. Det japanske studie i solide tumorer har slet ikke været omtalt. (før nu)

[E_L]

we discussed the Jun 6 here, the June11 is not Dara

[Mcjean]

Vi talte altså om studiet i Japan den 6/6 kl. 15.44

[Bulder]

ok, ja. Men disse tweeds omhandler det "discontinuede" MM-studie.

[Bulder]

Vi kan ikke regne med, hvad der (stadig) står på ct, sådan at forstå, at der helt klart er en vis forsinkelse. Dara-Tecentriq står stadig som rekrutterende.

[E_L]

that is the problem. that is why i asked JanssenEMEA, cc Genmab if these 2 updates could be as mistake; they couldnt be bothered to reply

[E_L]

Lets hope the GS analyst will be smart enough to ask that question to Jan tonight. i am not so sure ;-(

[mobbyduck1]

Lets not put any hope in GS, they have been Genmab Negative for a long time

[Mcjean]

Jan wil just do as he usually do, " i cant comment on that, its J&J you should ask about that".........end of story!

[E_L]